Composition:

  •  Amnocapace in the form of amnocapace hydrochloride

Dosage form:

  •  Solution for injection
  • Enocapace is an inhibitor of complement protein C5, which plays a key role in the complement cascade, the immune response system. Inhibition of C5 prevents the formation of a membrane-attacking complex (MAC) that damages cell membranes.

Indications for use:

  •  Paroxysmal nocturnal hemoglobinuria (APG)
  • Invossa-K injections are administered intravenously. The dose and frequency of injections are determined by the doctor depending on the individual needs of the patient.

Contraindications:

  •  Hypersensitivity to enocapace or any other component of the drug

The most common side effects associated with Invoicing are:

  •  Stomach pain
  •  Headache
  •  Nausea
  •  Shortness of breath
  •  The rash
  •  Hypertension
  •  Fever

Special instructions:

  • Patients with APH should regularly undergo platelet count and hemoglobin monitoring.
  •  Before the introduction of Invossa-K, it is necessary to conduct an allergy test for the drug.
  •  Invossa-K may interact with other medications, including immunosuppressants and anticoagulants.
  •  Care should be taken when using Invossa-K during pregnancy and lactation.

Storage conditions:

  •  Store in the refrigerator at a temperature of 2 to 8°C.
  •  Do not freeze.

Introduction instructions:

  •  Bring the Invoice to room temperature before administration.
  •  Inject the drug intravenously through a central venous catheter.
  •  Inject the drug at a rate of 1 ml/min.

Important:

  •  The information provided here is not a substitute for professional medical advice.
  •  Always consult your doctor or pharmacist before using any medicine.